Clinical Trial Update: A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML) [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial of clofarabine in Japanese patients with acute myeloid leukemia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Clofarabine (clofarabine)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Acute Myelogenous Leukemia | Phase 1 | Status: COMPLETED